(Q44537135)

3 December 2017

title

Outcomes of locally advanced breast cancer patients with ≥ 10 positive axillary lymph nodes (English)

1 reference

3 December 2017

0 references

7

Kadri Altundag

1 reference

3 December 2017

Emre Koca

1

1 reference

3 December 2017

Taha Y Kuzan

2

1 reference

3 December 2017

Omer Dizdar

3

1 reference

3 December 2017

Taner Babacan

4

1 reference

3 December 2017

Ilyas Sahin

5

1 reference

3 December 2017

Erhan Ararat

6

1 reference

3 December 2017

publication date

1 June 2013

1 reference

3 December 2017

1 reference

3 December 2017

volume

30

1 reference

3 December 2017

issue

3

1 reference

3 December 2017

page(s)

615

1 reference

https://scigraph.springernature.com/pub.10.1007/s12032-013-0615-7

3 December 2017

exact match

0 references

cites work

The global breast cancer burden: variations in epidemiology and survival.

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0615-7

Breast cancer incidence, 1980-2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0615-7

Prognostic and predictive factors in early-stage breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0615-7

Staging system for breast cancer: revisions for the 6th edition of the AJCC Cancer Staging Manual

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0615-7

Clinical outcome of breast cancer patients with N3a (≥10 positive lymph nodes) disease: has it changed over years?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0615-7

A gene-expression signature as a predictor of survival in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0615-7

The natural history of breast carcinoma in patients with > or = 10 metastatic axillary lymph nodes before and after the advent of adjuvant therapy: a multiinstitutional retrospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0615-7

Long-term prognosis of breast cancer patients with 10 or more positive lymph nodes treated with CMF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0615-7

Prognostic value of lymphangiogenesis and lymphovascular invasion in invasive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0615-7

Prognostic value of nodal ratios in node-positive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0615-7

Axillary lymph node ratio and total number of removed lymph nodes: predictors of survival in stage I and II breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0615-7

Lymph node ratio should be considered for incorporation into staging for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0615-7

The emerging issue of ratio of metastatic to resected lymph nodes in gastrointestinal cancers: an overview of literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0615-7

The prognostic value of ratio-based lymph node staging in resected non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-013-0615-7

Significance of pathological evaluation for lymphatic vessel invasion in invasive breast cancer

21 January 2018

1 reference

12 December 2020

Factors influencing the outcome of breast cancer patients with 10 or more metastasized axillary lymph nodes

1 reference

12 December 2020

Impact of lymph node ratio on survival in papillary thyroid cancer

1 reference

12 December 2020

Lymph node ratio: a proposed refinement of current axillary staging in breast cancer patients

1 reference

12 December 2020

Is there any prognostically different subgroup among patients with stage IIIC (any TN3M0) breast carcinoma?

1 reference

12 December 2020

The natural history of breast cancer with more than 10 positive nodes

1 reference

12 December 2020

Redefining the R1 resection for pancreatic ductal adenocarcinoma: tumour lymph nodal burden and lymph node ratio are the only prognostic factors associated with survival

1 reference

12 December 2020

Proposal of new classification for stage III breast cancer on the number and ratio of metastatic lymph nodes

1 reference

12 December 2020

Epidemiology of locally advanced breast cancer

1 reference

12 December 2020

Breast cancer patients with 10 or more involved axillary lymph nodes treated by multimodality therapy: influence of clinical presentation on outcome

1 reference

12 December 2020

Lymph node ratio as an alternative to pN staging in node-positive breast cancer

1 reference

12 December 2020

Clinical course of patients with breast cancer with ten or more positive nodes who were treated with doxorubicin-containing adjuvant therapy

1 reference

12 December 2020

10.1007/S12032-013-0615-7

Identifiers

DOI

1 reference

3 December 2017

1 reference